93%Confidence
0Views
FDASource
2026-04-14Date
Summary
Redness relief eye drops from K.C. Pharmaceuticals complete the pattern of sterility failures across their entire ophthalmic product line. The involvement of industrial and pharmacy distributors expands the potential exposure and liability.
Actionable: Conduct thorough review of all products manufactured by K.C. Pharmaceuticals and implement enhanced supplier qualification processes.
AI Confidence: 93%
Data Points
firmK.C. Pharmaceuticals, Inc
classificationClass II
statusOngoing
distributionNationwide in the US
productSterile EYE DROPS REDNESS LUBRICANT (glycerin 0.25% and naphazoline HCl 0.012%), 0.5 fl oz (15 mL) bottles; a) Industrial Eye Relief, Distributed by:
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now